Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829344 · ClinicalTrials.gov registry record · Phase 3
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
A Phase 3 study of Anesthesia, Local, sponsored by American Genomics.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04829344: Completed Phase 3 study of Anesthesia, Local, sponsored by American Genomics.
NCT04829344 is a Phase 3 study of Anesthesia, Local that has completed, run by American Genomics. The registered enrollment target is 120 participants, above the 76-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829344, a Phase 3 study of Anesthesia, Local, has completed, sponsored by American Genomics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic efficacy of AG-920 Sterile Topical Ophthalmic Solution.
Primary Outcome
Immediately following EACH pinch test, subjects will be asked "Was that painful" "Yes" or "NO."
Conditions Studied
Interventions
- DRUG Placebo
- DRUG AG-920
Study Locations (1)
Texas
- American Genomics Site 2 - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2021-03-30 |
| Est. Completion | 2021-05-10 |
| Phase | Phase 3 |
What the finished NCT04829344 record still lists
NCT04829344 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (58% higher).
The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04829344 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04829344 about?
NCT04829344 is a clinical study titled "A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution". This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic efficacy of AG-920 Sterile Topical Ophthalmic Solution.
What is the current status of trial NCT04829344?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2021-03-30. Estimated completion is 2021-05-10.
What conditions does trial NCT04829344 study?
This clinical trial studies the following conditions: Anesthesia, Local.
What interventions are being tested in trial NCT04829344?
The interventions under investigation include: Placebo (DRUG), AG-920 (DRUG).
Who is sponsoring clinical trial NCT04829344?
This trial is sponsored by American Genomics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04829344 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04829344's enrollment target sits among peer trials
120 5th of 18 higher than 14 of 18 other Anesthesia, Local trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia, Local trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
COMPLETED · Phase 3
-
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
RECRUITING · NA
-
Effect of Silver Diamine Fluoride on Local Anesthesia in Hypomineralized Molars
RECRUITING · NA
-
Obstetric Placement Study Using EST
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI